The side effects of GLP-1 medications are real, sometimes unpleasant, and occasionally the reason people discontinue therapy. The most common — nausea, constipation, fatigue, reflux — peak in the first 4–8 weeks on a new dose and generally diminish as the body adapts. Understanding why each side effect occurs and having specific tactics to address it dramatically improves the experience, particularly during the critical early period when habit formation matters most.
This guide addresses common, expected side effects. Severe or persistent vomiting, signs of pancreatitis (severe upper abdominal pain radiating to the back), or signs of thyroid masses should prompt immediate contact with your prescribing physician. These are rare but serious adverse events that require medical attention.
Nausea: The Most Common Complaint
Nausea occurs because GLP-1 receptors are found in the area postrema — the brain's vomiting center — and in the gastrointestinal tract. Slowed gastric emptying means food sits in the stomach longer, and the drug directly activates pathways associated with nausea. Most users report nausea peaks in the first 2 weeks on any new dose and subsides significantly by week 4–6.
- Eat small meals slowly — take 20 minutes minimum per meal, chew thoroughly
- Avoid strong food smells during nausea episodes; cold or room-temperature food produces less aroma
- Ginger — ginger tea, ginger chews, or ginger supplements — has modest clinical evidence for reducing nausea
- Peppermint tea can relax the stomach and reduce nausea in some users
- Avoid lying down for at least 2–3 hours after eating
- Eat bland, low-fat foods during nausea peaks: toast, crackers, broth, plain rice
- Stay hydrated — dehydration worsens nausea significantly
Pro Tip
Timing your injection matters for nausea management. Many users find that injecting before bed (for weekly doses) allows them to sleep through the worst of the initial nausea peak, waking with symptoms largely resolved.
Constipation: The Underreported Problem
Constipation affects a substantial minority of GLP-1 users — estimates from trial data range from 15–30% depending on the medication and dose. The mechanism is direct: slowed gastric motility doesn't stop at the stomach. Transit time through the entire gastrointestinal tract slows, giving more time for water to be absorbed from stool, resulting in harder, more difficult-to-pass bowel movements. Reduced overall food intake compounds the problem — less food volume means less stool bulk.
- Increase fiber intake gradually: aim for 25–35g daily from vegetables, fruits, and whole grains
- Hydration is critical — hard stool is predominantly a hydration problem; aim for at least 2.5–3L of water daily
- Magnesium glycinate (200–400mg before bed) is a gentle, well-tolerated option that draws water into the intestine
- Daily walking — even 15–20 minutes — stimulates intestinal motility
- Prunes or prune juice are old-fashioned but genuinely effective
- If constipation persists beyond 5–7 days, discuss MiraLax (polyethylene glycol) with your prescriber — it's safe and effective
Fatigue and Energy Dips
Many GLP-1 users report fatigue, particularly in the first 2–4 weeks on a new dose or after a dose increase. The causes are multiple: the body is adapting to significantly reduced caloric intake, electrolyte levels may be lower due to reduced food and fluid consumption, and disrupted sleep (from nausea) compounds daytime tiredness. Most users see fatigue resolve substantially by week 4–6.
- Don't drop below 1,000 calories daily — aggressive under-eating accelerates fatigue
- Prioritize electrolytes: sodium, potassium, and magnesium drop when food intake drops sharply
- A daily electrolyte packet (LMNT, Liquid IV, or similar) is often enough to resolve fatigue within 2–3 days if electrolytes are the cause
- Protect sleep: nausea is often worse lying flat — slightly elevating the head of the bed helps
- Reduce training intensity during dose-increase weeks; this is not the time for personal records
Acid Reflux and GERD Symptoms
Slowed gastric emptying means food and stomach acid spend more time in contact with the lower esophageal sphincter, increasing the likelihood of reflux. Users with pre-existing GERD often see their symptoms worsen on GLP-1 therapy. New-onset reflux symptoms are also common.
- Elevate the head of your bed 4–6 inches (sleeping on extra pillows is insufficient — use bed risers or a wedge pillow)
- Avoid eating within 3 hours of lying down
- Reduce or eliminate common reflux triggers: alcohol, caffeine, spicy foods, citrus, mint
- Over-the-counter antacids (calcium carbonate) provide immediate relief
- If persistent, discuss H2 blockers (famotidine) or PPIs (omeprazole) with your prescriber
Nausea vs Vomiting: When to Be Concerned
Nausea without vomiting is common and manageable. Frequent vomiting is different. If you're vomiting more than once per day for more than 2–3 days, or if you cannot keep liquids down, contact your prescriber. Persistent vomiting leads to dehydration and electrolyte abnormalities that require medical management. It may also indicate that your dose is too high for your current level of adaptation — a temporary dose reduction is a legitimate clinical tool, not a failure.
Diarrhea: Less Common but Significant
Some users experience loose stools or diarrhea, particularly in the first weeks of treatment. This is less common than constipation but more disruptive when it occurs. The cause is variable: some users experience accelerated transit of certain food types, others have a response to the medication's effect on gut motility that produces intermittent loose stools. The practical approach: identify and temporarily avoid foods that seem to trigger episodes (common culprits are high-fat foods, sugar alcohols, and dairy), stay hydrated, and use over-the-counter loperamide (Imodium) for acute episodes. Most diarrhea resolves within 4–6 weeks as the gut adapts.
Side effect intensity is strongly dose-dependent. If side effects are intolerable on your current dose, talk to your prescriber about extending the time at your current dose before escalating. There's no clinical mandate to follow a fixed titration schedule — slower titration often means substantially better tolerability.